<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01753427</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-RCN-XXX-2012/1</org_study_id>
    <nct_id>NCT01753427</nct_id>
  </id_info>
  <brief_title>Perception of Symptom Variability in COPD</brief_title>
  <official_title>Perception of Symptom Variability in Chinese COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <brief_summary>
    <textblock>
      The objective of the study is to assess patient's perception with stable state COPD on
      symptom variability and to describe how symptom variability impacts daily quality of life in
      Chinese COPD patient with moderate, severe or very severe airflow limitation from tier 3
      hospitals in China where most of COPD patients are diagnosed and treated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The variability of symptoms due to COPD throughout the day</measure>
    <time_frame>Day 1</time_frame>
    <description>To ask subject, which symptoms（breathlessness, chest tightness, coughing, wheezing, phlegm）is COPD symptoms and exist throughout the day
To ask subject , whether COPD symptoms variability throughout the day exists or not ;
To ask subject , which (on waking, later in the morning, in the afternoon, in the evening, at night) is the most likely occurring time of these symptoms;
To ask subject , Which (on waking, later in the morning, in the afternoon, in the evening, at night) is the most troublesome time of these symptoms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The impact of COPD symptoms on patient's daily living activities and sleep quality</measure>
    <time_frame>Day 1</time_frame>
    <description>To ask subject, Whether essential daily activities affected by COPD symptoms and the type of following: going up and downstairs, Going out of shopping, doing sport/exercise, doing housework, or all of these
To ask subject, Whether sleep quality affected by COPD symptoms and the type of following: difficulty falling sleep, frequent waking during night, early waking in the morning, or all of these</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The impact of COPD symptoms on morning activities</measure>
    <time_frame>Day 1</time_frame>
    <description>To ask subject, When [getting out of bed, dressing, washing, eating breakfast, morning activity after breakfast (indoor activity, including housework) , morning exercise (outdoor activity, such as walking, sport, etc)] the essential morning activities affected by COPD symptoms:
To ask subject, The extent of these morning activities affected: not at all, a little, moderate, severe, extremely severe resulting to feel difficult to complete independently, extremely severe resulting to complete under others help or cannot complete at all</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total CAT score</measure>
    <time_frame>Day 1</time_frame>
    <description>CAT (COPD assessment test) has a broader coverage of the impact of COPD on the patient's daily life and well-being.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total MMRC score</measure>
    <time_frame>Day 1</time_frame>
    <description>MMRC (Modified Medical Research Council Questionnaire for Assessing the Severity of Breathlessness) assesses disability due to breathlessness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's perception on COPD and COPD treatments</measure>
    <time_frame>Day 1</time_frame>
    <description>To ask subject, Seek for treatment only when symptoms occur/worsening or regularly visit physician and take medicine(s)
To ask subject, Whether Knowing about how and when to use their medications
To ask subject, Usually taking their medication(s) required by physician to be used in the morning at what time: before getting out of bed, within 30 minutes after getting out of bed, within 30 minutes to 1 hour after getting out of bed, over 1 hour after getting out of bed, no regular time</description>
  </secondary_outcome>
  <enrollment type="Actual">1058</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Out-patient, male or female aged 40 years and over and Clinical diagnosis of COPD at least
        6 months
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provision of subject informed consent

          -  Out-patient

          -  Clinical diagnosis of COPD at least 6 months

          -  Lung function based on data available within 3 months in medical records confirming
             FEV1&lt;80% normal predicted (post-bronchodilator) and FEV1/FVC&lt;0.7 (post-bronchodilator)

        Exclusion Criteria:

          -  Participation in any interventional study involving investigational drugs; Patient
             inability to understand the study procedures or inability/reluctance to answer
             questionnaire

          -  Ongoing exacerbation of COPD or exacerbation within the previous 3 months. An
             exacerbation is defined as a worsening of COPD symptoms leading to a treatment with
             antibiotics and/or a short course of system steroids and/or hospitalisation or
             emergency

          -  History of asthma and/or allergic rhinitis, Lung cancer or any other significant
             respiratory disease such as bronchiectasis, lung fibrosis, interstitial lung disease,
             tuberculosis, sarcoidosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&amp;studyid=1036&amp;filename=NIS-RCN-XXX-2012-1_Report_Synopsis.pdf</url>
    <description>CSR Synopsis</description>
  </link>
  <link>
    <url>http://onlinelibrary.wiley.com/doi/10.1111/resp.12417_6/epdf</url>
    <description>YAO Wanzhen et al COPD symptom NIS abstract_2014 APSR. Abstract ID: P-F-090</description>
  </link>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2012</study_first_submitted>
  <study_first_submitted_qc>December 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2012</study_first_posted>
  <last_update_submitted>June 14, 2016</last_update_submitted>
  <last_update_submitted_qc>June 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD,</keyword>
  <keyword>symptoms,</keyword>
  <keyword>Non-Interventional study,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

